Jpmorgan Chase & CO Accolade, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Accolade, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,957,326 shares of ACCD stock, worth $9.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,957,326
Previous 5,331,319
44.53%
Holding current value
$9.32 Million
Previous $55.9 Million
81.05%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ACCD
# of Institutions
169Shares Held
65.7MCall Options Held
61KPut Options Held
566K-
Black Rock Inc. New York, NY6.16MShares$19.4 Million0.0% of portfolio
-
Brown Advisory Inc5.45MShares$17.2 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.38MShares$17 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$13 Million0.0% of portfolio
-
Ah Equity Partners Iv (Parallel), L.L.C. Menlo Park, CA3.78MShares$11.9 Million88.81% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $227M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...